Anti-hepatic carcinoma mechanisms of calycosin through targeting ferroptosis

Ferroptosis, a pathologic state induced by lipid-driven oxidative stress, is associated with the development of human cancers. Calycosin, a natural compound with antioxidant and anti-inflammatory activities, has promising antitumor effects. However, the ferroptosis-related mechanism of calycosin in...

Full description

Saved in:
Bibliographic Details
Published inIntelligent medicine Vol. 3; no. 3; pp. 173 - 179
Main Authors Nie, Litao, Liao, Yimei, Zhou, Rui, Liang, Xiao, Wan, Xiaowei, Li, Xin, Su, Min
Format Journal Article
LanguageEnglish
Published Elsevier B.V 01.08.2023
Elsevier
Subjects
Bioinformatics
Calycosin
Ferroptosis
Hepatic carcinoma
Pharmacologic target
Pharmacologic target
Ferroptosis
Calycosin
Bioinformatics
Hepatic carcinoma
Online AccessGet full text

Cover

Abstract Ferroptosis, a pathologic state induced by lipid-driven oxidative stress, is associated with the development of human cancers. Calycosin, a natural compound with antioxidant and anti-inflammatory activities, has promising antitumor effects. However, the ferroptosis-related mechanism of calycosin in the treatment of hepatic carcinoma has not been reported. This study applied network pharmacology and bioinformatic approaches (including Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis) to investigate the pharmacologic targets and mechanism of action of calycosin in the treatment of hepatic carcinoma through targeting ferroptosis. By searching online databases including The Cancer Genome Atlas, FerrDb, GeneCards, SwissTargetPrediction, SuperPred, BindingDB, TargetNet, BATMAN-TCM, and Drugbank, we identified 13 ferroptosis-related putative target genes of calycosin against hepatic carcinoma including IL-6, PTGS2, SRC, HRAS, NQO1, NOX4, PGK1, G6PD, GPI, MIF, NOS2, ALDOA, and SQSTM1. Molecular docking analysis revealed that calycosin potentially binded directly with the target proteins IL-6, PTGS2, and SRC. Functional enrichment analysis of these proteins indicated that they were involved in gluconeogenesis and apoptosis through regulation of ERK1, ERK2, and MAPK activities (P < 0.05). Calycosin exerts antitumor effects in hepatic carcinoma by targeting ferroptosis through regulation of IL-6, PTGS2, and SRC.
AbstractList Background: Ferroptosis, a pathologic state induced by lipid-driven oxidative stress, is associated with the development of human cancers. Calycosin, a natural compound with antioxidant and anti-inflammatory activities, has promising antitumor effects. However, the ferroptosis-related mechanism of calycosin in the treatment of hepatic carcinoma has not been reported. Methods: This study applied network pharmacology and bioinformatic approaches (including Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis) to investigate the pharmacologic targets and mechanism of action of calycosin in the treatment of hepatic carcinoma through targeting ferroptosis. By searching online databases including The Cancer Genome Atlas, FerrDb, GeneCards, SwissTargetPrediction, SuperPred, BindingDB, TargetNet, BATMAN-TCM, and Drugbank, we identified 13 ferroptosis-related putative target genes of calycosin against hepatic carcinoma including IL-6, PTGS2, SRC, HRAS, NQO1, NOX4, PGK1, G6PD, GPI, MIF, NOS2, ALDOA, and SQSTM1. Results: Molecular docking analysis revealed that calycosin potentially binded directly with the target proteins IL-6, PTGS2, and SRC. Functional enrichment analysis of these proteins indicated that they were involved in gluconeogenesis and apoptosis through regulation of ERK1, ERK2, and MAPK activities (P < 0.05). Conclusion: Calycosin exerts antitumor effects in hepatic carcinoma by targeting ferroptosis through regulation of IL-6, PTGS2, and SRC.
Ferroptosis, a pathologic state induced by lipid-driven oxidative stress, is associated with the development of human cancers. Calycosin, a natural compound with antioxidant and anti-inflammatory activities, has promising antitumor effects. However, the ferroptosis-related mechanism of calycosin in the treatment of hepatic carcinoma has not been reported. This study applied network pharmacology and bioinformatic approaches (including Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis) to investigate the pharmacologic targets and mechanism of action of calycosin in the treatment of hepatic carcinoma through targeting ferroptosis. By searching online databases including The Cancer Genome Atlas, FerrDb, GeneCards, SwissTargetPrediction, SuperPred, BindingDB, TargetNet, BATMAN-TCM, and Drugbank, we identified 13 ferroptosis-related putative target genes of calycosin against hepatic carcinoma including IL-6, PTGS2, SRC, HRAS, NQO1, NOX4, PGK1, G6PD, GPI, MIF, NOS2, ALDOA, and SQSTM1. Molecular docking analysis revealed that calycosin potentially binded directly with the target proteins IL-6, PTGS2, and SRC. Functional enrichment analysis of these proteins indicated that they were involved in gluconeogenesis and apoptosis through regulation of ERK1, ERK2, and MAPK activities (P < 0.05). Calycosin exerts antitumor effects in hepatic carcinoma by targeting ferroptosis through regulation of IL-6, PTGS2, and SRC.
Author Nie, Litao
Zhou, Rui
Liang, Xiao
Liao, Yimei
Su, Min
Wan, Xiaowei
Li, Xin
Author_xml – sequence: 1
  givenname: Litao
  surname: Nie
  fullname: Nie, Litao
  organization: Key Laboratory of Environmental Pollution and Integrative Omics, Guilin Medical University, Guilin, Guangxi Zhuang Autonomous Region 541004, China
– sequence: 2
  givenname: Yimei
  surname: Liao
  fullname: Liao, Yimei
  organization: Department of Clinical Pharmacy, Guigang City People's Hospital, The Eighth Affiliated Hospital of Guangxi Medical University, Guigang, Guangxi Zhuang Autonomous Region 537100, China
– sequence: 3
  givenname: Rui
  surname: Zhou
  fullname: Zhou, Rui
  organization: Department of Hepatobiliary Surgery, Guigang City People's Hospital, The Eighth Affiliated Hospital of Guangxi Medical University, Guigang, Guangxi Zhuang Autonomous Region 537199, China
– sequence: 4
  givenname: Xiao
  surname: Liang
  fullname: Liang, Xiao
  organization: Key Laboratory of Environmental Pollution and Integrative Omics, Guilin Medical University, Guilin, Guangxi Zhuang Autonomous Region 541004, China
– sequence: 5
  givenname: Xiaowei
  surname: Wan
  fullname: Wan, Xiaowei
  organization: Key Laboratory of Environmental Pollution and Integrative Omics, Guilin Medical University, Guilin, Guangxi Zhuang Autonomous Region 541004, China
– sequence: 6
  givenname: Xin
  surname: Li
  fullname: Li, Xin
  organization: Key Laboratory of Environmental Pollution and Integrative Omics, Guilin Medical University, Guilin, Guangxi Zhuang Autonomous Region 541004, China
– sequence: 7
  givenname: Min
  surname: Su
  fullname: Su, Min
  organization: Key Laboratory of Environmental Pollution and Integrative Omics, Guilin Medical University, Guilin, Guangxi Zhuang Autonomous Region 541004, China
BookMark eNp9kE1qwzAQhUVJoWmaC3TlC9gdybYsQzch9A8C3bRrIcsjWya2guQWcvsqTSlddTXDzLzHvO-aLCY3ISG3FDIKlN8NmR2xzRgwlgHPAOgFWTLOq5QC44s__RVZhzAAAKugLopiSXababZpjwc1W51o5bWd3KiSEXWvJhvGkDgT5_ujdsFOydx799H1yax8h7OdusSg9-4wx224IZdG7QOuf-qKvD8-vG2f093r08t2s0t1zumclkwjRY6Uosgp43kDeSk0b01dNwBFITjNc6SK1vGwKVhdAi8FagaV0m2dr8jL2bd1apAHb0flj9IpK78HzndS-Zhnj7ISlWgRaMFLXRjFamyMYa1hXCgBVRm92NlLexeCR_PrR0Ge8MpBnvDKE14JXEa8UXR_FmFM-WnRy6AtThpb61HP8Q37n_wLJzSFAg
Cites_doi 10.1038/srep21146
10.3389/fphar.2021.742349
10.1016/j.abb.2020.108440
10.1093/nar/gkv1072
10.3892/ol.2015.3706
10.1107/S0907444998009378
10.1186/s13045-019-0806-6
10.1038/nmeth.2212
10.1016/j.brainresbull.2021.06.014
10.1155/2013/317926
10.1016/j.ijbiomac.2021.06.159
10.1039/D1FO01070K
10.1002/biof.1826
10.1016/j.etap.2019.103200
10.1016/j.jep.2019.01.023
10.1093/nar/gkz382
10.1038/s41418-022-00941-0
10.1080/13880209.2022.2067572
10.1093/nar/gkv007
10.1093/nar/gkw1099
10.7150/thno.58739
10.4103/jrms.JRMS_846_17
10.1038/ng0802-339
10.1038/s41575-019-0186-y
10.1016/S0140-6736(15)61412-X
10.1016/j.phrs.2012.04.005
10.15252/embj.2021107680
10.1093/nar/gkx1037
10.7150/jca.52298
10.1038/s41388-021-02058-z
10.1016/j.freeradbiomed.2018.09.043
10.1172/JCI144703
10.1007/s12094-021-02669-8
10.3322/caac.21654
10.3389/fendo.2021.714909
10.1016/j.tiv.2020.105052
10.1016/j.ejmech.2021.113804
10.1038/s41598-021-87812-9
10.1039/D0FO00421A
10.1007/s13577-020-00431-w
10.1016/j.canlet.2021.10.024
10.1016/S0168-8278(01)00077-0
10.1016/j.biocel.2021.106094
10.1016/j.canlet.2021.07.011
10.1093/database/baaa021
10.1056/NEJMra1713263
10.1080/21655979.2021.1985328
10.1074/jbc.RA120.015779
10.1080/21655979.2021.1964158
10.1038/75556
10.1093/bib/bbab425
10.1002/ctm2.600
10.1007/s10822-016-9915-2
10.1038/s41580-020-00324-8
10.1016/j.expneurol.2022.114100
10.1002/ijc.28159
10.1002/cpbi.5
10.3390/ijms22179453
10.1016/j.cell.2019.08.052
10.14814/phy2.15263
10.1016/j.jhep.2018.07.004
10.1615/CritRevEukaryotGeneExpr.2021038907
ContentType Journal Article
Copyright 2022 The Author(s)
Copyright_xml – notice: 2022 The Author(s)
DBID 6I.
AAFTH
AAYXX
CITATION
DOA
DOI 10.1016/j.imed.2022.06.001
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
DatabaseTitleList

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
EISSN 2667-1026
EndPage 179
ExternalDocumentID oai_doaj_org_article_7878de01465c4fa29ebff2df268a8075
10_1016_j_imed_2022_06_001
S2667102622000481
GroupedDBID .1-
.FO
6I.
AAEDW
AAFTH
AAXUO
AFCTW
AFRHN
AJUYK
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
EBS
FDB
GROUPED_DOAJ
M41
M~E
ROL
Z5R
0R~
0SF
AALRI
AAYXX
ADVLN
AFJKZ
AITUG
AKRWK
CITATION
ID FETCH-LOGICAL-c361t-52ce1e6e11e831263b0358c6df99b004486133e1a19ce1b42950658ec207acd93
IEDL.DBID DOA
ISSN 2667-1026
IngestDate Fri Oct 04 12:58:33 EDT 2024
Thu Sep 26 18:23:42 EDT 2024
Sat Sep 30 17:11:22 EDT 2023
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Pharmacologic target
Ferroptosis
Calycosin
Bioinformatics
Hepatic carcinoma
Language English
License This is an open access article under the CC BY license.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c361t-52ce1e6e11e831263b0358c6df99b004486133e1a19ce1b42950658ec207acd93
OpenAccessLink https://doaj.org/article/7878de01465c4fa29ebff2df268a8075
PageCount 7
ParticipantIDs doaj_primary_oai_doaj_org_article_7878de01465c4fa29ebff2df268a8075
crossref_primary_10_1016_j_imed_2022_06_001
elsevier_sciencedirect_doi_10_1016_j_imed_2022_06_001
PublicationCentury 2000
PublicationDate August 2023
2023-08-00
2023-08-01
PublicationDateYYYYMMDD 2023-08-01
PublicationDate_xml – month: 08
  year: 2023
  text: August 2023
PublicationDecade 2020
PublicationTitle Intelligent medicine
PublicationYear 2023
Publisher Elsevier B.V
Elsevier
Publisher_xml – name: Elsevier B.V
– name: Elsevier
References Zhang, Wang, Zhu (bib0016) 2013; 2013
Ritchie, Phipson, Wu (bib0020) 2015; 43
Meshram, Bhise, Makhal (bib0047) 2021; 225
Li, Guo, Li (bib0031) 2020; 11
Zhou, Huang, Xing (bib0059) 2022; 32
Dai, Wang, Peng (bib0045) 2022; 524
Daina, Michielin, Zoete (bib0024) 2019; 47
Liang, Tang, Huang (bib0052) 2022; 354
Jing, Wang, Li (bib0005) 2021; 11
Zhou, Wu, Su (bib0012) 2019; 70
Hirschhorn, Stockwell (bib0009) 2019; 133
Huang, Shen, Wang (bib0040) 2022; 60
Chen, Li, Ge (bib0008) 2022; 29
Fei, Lijuan, Jing (bib0068) 2021; 34
Wang, Lu, Zhao (bib0006) 2019; 12
Roskoski (bib0065) 2012; 66
Wang, Jin, Gao (bib0067) 2018; 69
Saito, Smoot, Ono (bib0032) 2012; 9
Yang, Sun, Sun (bib0048) 2021; 12
Hsu, Cheng, Mgbeahuruike (bib0063) 2021; 22
Zhao, Qin, Liang (bib0013) 2021; 12
Peng, Zhu, Yang (bib0050) 2021; 174
Cao, Zao, Xue (bib0035) 2021; 11
Wei, Wu, Cheng (bib0037) 2021; 23
Siegel, Miller, Fuchs (bib0002) 2021; 71
Hino, Yanatori, Hara (bib0043) 2021
Jiang, Stockwell, Conrad (bib0011) 2021; 22
Sussman, Lin, Jiang (bib0034) 1998; 54
Li, Xu, Qu (bib0060) 2022
Yang, Khan, Sun (bib0017) 2021; 185
Liu, Gou, Xiang (bib0061) 2021; 40
The UniProt Consortium (bib0023) 2017; 45
Li, Huang (bib0041) 2021; 24
Louandre, Ezzoukhry, Godin (bib0010) 2013; 133
Tognoli, Vlahov, Steenbeek (bib0053) 2021; 40
Ashburner, Ball, Blake (bib0033) 2000; 25
Stelzer, Rosen, Plaschkes (bib0021) 2016; 54
Yang, Hainaut, Gores (bib0003) 2019; 16
Zhou, Bao (bib0022) 2020; 2020
Thorgeirsson, Grisham (bib0036) 2002; 31
Gilson, Liu, Baitaluk (bib0026) 2016; 44
Yao, Dong, Che (bib0027) 2016; 30
Li, Jiang, Toyokuni (bib0064) 2020; 689
Wang, Liu, Chiou (bib0066) 2021; 520
Hu, Chen, Huang (bib0055) 2021; 13
Sun, Han, Yang (bib0030) 2021; 2021
Gallo, Goede, Preissner (bib0025) 2022
Song, Lee, Kim (bib0054) 2021; 11
Zhao, Wu, Wang (bib0056) 2015; 10
Villanueva (bib0001) 2019; 380
Qin, Huang, Huang (bib0019) 2021; 12
Elkhoudary, Elmougy, Elsaid (bib0044) 2021; 26
Schweitzer, Horn, Mikolajczyk (bib0004) 2015; 386
Gao, Zhu, Dong (bib0007) 2019; 179
Chen, Chen, Wang (bib0051) 2021; 296
Rishi, Huang, Subramaniam (bib0042) 2021; 141
Rodgers (bib0058) 2022; 10
Liu, Piao, Xu (bib0014) 2021; 70
Chi, Liu, Wei (bib0049) 2021; 12
Xiang, Chen, Liu (bib0062) 2021; 131
Ni, Fan, Zhang (bib0015) 2019; 242
Li, Yu, Li (bib0018) 2021; 12
Wishart, Feunang, Guo (bib0029) 2018; 46
Liu, Guo, Wang (bib0028) 2016; 6
Ito, Kawakatsu, Takeda (bib0057) 2001; 35
Han, Li, Yang (bib0046) 2021; 12
Siegel (10.1016/j.imed.2022.06.001_bib0002) 2021; 71
Yao (10.1016/j.imed.2022.06.001_bib0027) 2016; 30
Song (10.1016/j.imed.2022.06.001_bib0054) 2021; 11
Hsu (10.1016/j.imed.2022.06.001_bib0063) 2021; 22
Liu (10.1016/j.imed.2022.06.001_bib0028) 2016; 6
Rishi (10.1016/j.imed.2022.06.001_bib0042) 2021; 141
Jiang (10.1016/j.imed.2022.06.001_bib0011) 2021; 22
Fei (10.1016/j.imed.2022.06.001_bib0068) 2021; 34
Sun (10.1016/j.imed.2022.06.001_bib0030) 2021; 2021
Wei (10.1016/j.imed.2022.06.001_bib0037) 2021; 23
Ritchie (10.1016/j.imed.2022.06.001_bib0020) 2015; 43
Zhou (10.1016/j.imed.2022.06.001_bib0059) 2022; 32
Zhou (10.1016/j.imed.2022.06.001_bib0022) 2020; 2020
The UniProt Consortium (10.1016/j.imed.2022.06.001_bib0023) 2017; 45
Sussman (10.1016/j.imed.2022.06.001_bib0034) 1998; 54
Li (10.1016/j.imed.2022.06.001_bib0041) 2021; 24
Liu (10.1016/j.imed.2022.06.001_bib0061) 2021; 40
Yang (10.1016/j.imed.2022.06.001_bib0048) 2021; 12
Saito (10.1016/j.imed.2022.06.001_bib0032) 2012; 9
Cao (10.1016/j.imed.2022.06.001_bib0035) 2021; 11
Louandre (10.1016/j.imed.2022.06.001_bib0010) 2013; 133
Liu (10.1016/j.imed.2022.06.001_bib0014) 2021; 70
Rodgers (10.1016/j.imed.2022.06.001_bib0058) 2022; 10
Li (10.1016/j.imed.2022.06.001_bib0060) 2022
Yang (10.1016/j.imed.2022.06.001_bib0017) 2021; 185
Xiang (10.1016/j.imed.2022.06.001_bib0062) 2021; 131
Wishart (10.1016/j.imed.2022.06.001_bib0029) 2018; 46
Yang (10.1016/j.imed.2022.06.001_bib0003) 2019; 16
Meshram (10.1016/j.imed.2022.06.001_bib0047) 2021; 225
Liang (10.1016/j.imed.2022.06.001_bib0052) 2022; 354
Wang (10.1016/j.imed.2022.06.001_bib0067) 2018; 69
Chen (10.1016/j.imed.2022.06.001_bib0008) 2022; 29
Gallo (10.1016/j.imed.2022.06.001_bib0025) 2022
Ito (10.1016/j.imed.2022.06.001_bib0057) 2001; 35
Chi (10.1016/j.imed.2022.06.001_bib0049) 2021; 12
Peng (10.1016/j.imed.2022.06.001_bib0050) 2021; 174
Zhao (10.1016/j.imed.2022.06.001_bib0056) 2015; 10
Villanueva (10.1016/j.imed.2022.06.001_bib0001) 2019; 380
Elkhoudary (10.1016/j.imed.2022.06.001_bib0044) 2021; 26
Han (10.1016/j.imed.2022.06.001_bib0046) 2021; 12
Roskoski (10.1016/j.imed.2022.06.001_bib0065) 2012; 66
Dai (10.1016/j.imed.2022.06.001_bib0045) 2022; 524
Hino (10.1016/j.imed.2022.06.001_bib0043) 2021
Tognoli (10.1016/j.imed.2022.06.001_bib0053) 2021; 40
Gao (10.1016/j.imed.2022.06.001_bib0007) 2019; 179
Li (10.1016/j.imed.2022.06.001_bib0064) 2020; 689
Ni (10.1016/j.imed.2022.06.001_bib0015) 2019; 242
Wang (10.1016/j.imed.2022.06.001_bib0006) 2019; 12
Schweitzer (10.1016/j.imed.2022.06.001_bib0004) 2015; 386
Li (10.1016/j.imed.2022.06.001_bib0018) 2021; 12
Li (10.1016/j.imed.2022.06.001_bib0031) 2020; 11
Thorgeirsson (10.1016/j.imed.2022.06.001_bib0036) 2002; 31
Hirschhorn (10.1016/j.imed.2022.06.001_bib0009) 2019; 133
Daina (10.1016/j.imed.2022.06.001_bib0024) 2019; 47
Zhang (10.1016/j.imed.2022.06.001_bib0016) 2013; 2013
Gilson (10.1016/j.imed.2022.06.001_bib0026) 2016; 44
Zhou (10.1016/j.imed.2022.06.001_bib0012) 2019; 70
Chen (10.1016/j.imed.2022.06.001_bib0051) 2021; 296
Qin (10.1016/j.imed.2022.06.001_bib0019) 2021; 12
Huang (10.1016/j.imed.2022.06.001_bib0040) 2022; 60
Hu (10.1016/j.imed.2022.06.001_bib0055) 2021; 13
Ashburner (10.1016/j.imed.2022.06.001_bib0033) 2000; 25
Wang (10.1016/j.imed.2022.06.001_bib0066) 2021; 520
Stelzer (10.1016/j.imed.2022.06.001_bib0021) 2016; 54
Zhao (10.1016/j.imed.2022.06.001_bib0013) 2021; 12
Jing (10.1016/j.imed.2022.06.001_bib0005) 2021; 11
References_xml – volume: 40
  start-page: 6707
  year: 2021
  end-page: 6719
  ident: bib0061
  article-title: O-GlcNAc modified-TIP60/KAT5 is required for PCK1 deficiency-induced HCC metastasis
  publication-title: Oncogene
  contributor:
    fullname: Xiang
– volume: 31
  start-page: 339
  year: 2002
  end-page: 346
  ident: bib0036
  article-title: Molecular pathogenesis of human hepatocellular carcinoma
  publication-title: Nat Genet
  contributor:
    fullname: Grisham
– volume: 70
  year: 2019
  ident: bib0012
  article-title: Bioinformatic and experimental data decipher the pharmacological targets and mechanisms of plumbagin against hepatocellular carcinoma
  publication-title: Environ Toxicol Pharmacol
  contributor:
    fullname: Su
– volume: 12
  start-page: 133
  year: 2019
  ident: bib0006
  article-title: Tumorigenesis, diagnosis, and therapeutic potential of exosomes in liver cancer
  publication-title: J Hematol Oncol
  contributor:
    fullname: Zhao
– volume: 380
  start-page: 1450
  year: 2019
  end-page: 1462
  ident: bib0001
  article-title: Hepatocellular Carcinoma
  publication-title: N Engl J Med
  contributor:
    fullname: Villanueva
– volume: 225
  year: 2021
  ident: bib0047
  article-title: Synthetically-tailored and nature-derived dual COX-2/5-LOX inhibitors: structural aspects and SAR
  publication-title: Eur J Med Chem
  contributor:
    fullname: Makhal
– volume: 43
  start-page: e47
  year: 2015
  ident: bib0020
  article-title: limma powers differential expression analyses for RNA-sequencing and microarray studies
  publication-title: Nucleic Acids Res
  contributor:
    fullname: Wu
– volume: 12
  start-page: 9939
  year: 2021
  end-page: 9948
  ident: bib0013
  article-title: Exploring anti-liver cancer targets and mechanisms of oxyresveratrol: in silico and verified findings
  publication-title: Bioengineered
  contributor:
    fullname: Liang
– volume: 34
  start-page: 177
  year: 2021
  end-page: 186
  ident: bib0068
  article-title: Molecular characteristics associated with ferroptosis in hepatocellular carcinoma progression
  publication-title: Hum Cell
  contributor:
    fullname: Jing
– volume: 32
  start-page: 35
  year: 2022
  end-page: 47
  ident: bib0059
  article-title: MiR-93-5P represses the gluconeogenesis of hepatocellular carcinoma while boosting its glycolysis and malignant progression by suppressing PCK1
  publication-title: Crit Rev Eukaryot Gene Expr
  contributor:
    fullname: Xing
– volume: 71
  start-page: 7
  year: 2021
  end-page: 33
  ident: bib0002
  article-title: Cancer Statistics, 2021
  publication-title: CA Cancer J Clin
  contributor:
    fullname: Fuchs
– volume: 10
  start-page: e15263
  year: 2022
  ident: bib0058
  article-title: Glucagon, cyclic AMP, and hepatic glucose mobilization: a half-century of uncertainty
  publication-title: Physiol Rep
  contributor:
    fullname: Rodgers
– volume: 179
  start-page: 561
  year: 2019
  end-page: 577
  ident: bib0007
  article-title: Integrated proteogenomic characterization of HBV-related hepatocellular carcinoma
  publication-title: Cell
  contributor:
    fullname: Dong
– volume: 35
  start-page: 68
  year: 2001
  end-page: 73
  ident: bib0057
  article-title: Activation of c-Src gene product in hepatocellular carcinoma is highly correlated with the indices of early stage phenotype
  publication-title: J Hepatol
  contributor:
    fullname: Takeda
– volume: 16
  start-page: 589
  year: 2019
  end-page: 604
  ident: bib0003
  article-title: A global view of hepatocellular carcinoma: trends, risk, prevention and management
  publication-title: Nat Rev Gastroenterol Hepatol
  contributor:
    fullname: Gores
– volume: 44
  start-page: D1045
  year: 2016
  end-page: D1053
  ident: bib0026
  article-title: BindingDB in 2015: a public database for medicinal chemistry, computational chemistry and systems pharmacology
  publication-title: Nucleic Acids Res
  contributor:
    fullname: Baitaluk
– volume: 30
  start-page: 413
  year: 2016
  end-page: 424
  ident: bib0027
  article-title: TargetNet: a web service for predicting potential drug-target interaction profiling via multi-target SAR models
  publication-title: J Comput Aided Mol Des
  contributor:
    fullname: Che
– volume: 11
  start-page: 4765
  year: 2020
  end-page: 4772
  ident: bib0031
  article-title: Therapeutic target and molecular mechanism of vitamin C-treated pneumonia: a systematic study of network pharmacology
  publication-title: Food Funct
  contributor:
    fullname: Li
– volume: 40
  year: 2021
  ident: bib0053
  article-title: RASSF1C oncogene elicits amoeboid invasion, cancer stemness, and extracellular vesicle release via a SRC/Rho axis
  publication-title: EMBO J
  contributor:
    fullname: Steenbeek
– volume: 29
  start-page: 467
  year: 2022
  end-page: 480
  ident: bib0008
  article-title: The multifaceted role of ferroptosis in liver disease
  publication-title: Cell Death Differ
  contributor:
    fullname: Ge
– year: 2021
  ident: bib0043
  article-title: Iron and liver cancer: an inseparable connection
  publication-title: FEBS J
  contributor:
    fullname: Hara
– volume: 2020
  start-page: baaa021
  year: 2020
  ident: bib0022
  article-title: FerrDb: a manually curated resource for regulators and markers of ferroptosis and ferroptosis-disease associations
  publication-title: Database
  contributor:
    fullname: Bao
– volume: 11
  start-page: e600
  year: 2021
  ident: bib0005
  article-title: Ultrasound-guided percutaneous metal-organic frameworks based codelivery system of doxorubicin/acetazolamide for hepatocellular carcinoma therapy
  publication-title: Clin Transl Med
  contributor:
    fullname: Li
– volume: 133
  start-page: 130
  year: 2019
  end-page: 143
  ident: bib0009
  article-title: The development of the concept of ferroptosis
  publication-title: Free Radic Biol Med
  contributor:
    fullname: Stockwell
– volume: 174
  start-page: 250
  year: 2021
  end-page: 259
  ident: bib0050
  article-title: N2L, a novel lipoic acid-niacin dimer, attenuates ferroptosis and decreases lipid peroxidation in HT22 cells
  publication-title: Brain Res Bull
  contributor:
    fullname: Yang
– volume: 11
  start-page: 8402
  year: 2021
  ident: bib0035
  article-title: The mechanism of TiaoGanYiPi formula for treating chronic hepatitis B by network pharmacology and molecular docking verification
  publication-title: Sci Rep
  contributor:
    fullname: Xue
– volume: 689
  year: 2020
  ident: bib0064
  article-title: Role of carbonic anhydrases in ferroptosis-resistance
  publication-title: Arch Biochem Biophys
  contributor:
    fullname: Toyokuni
– volume: 12
  year: 2021
  ident: bib0019
  article-title: Integrated analysis and finding reveal anti-liver cancer targets and mechanisms of pachyman (Poria cocos Polysaccharides)
  publication-title: Front Pharmacol
  contributor:
    fullname: Huang
– volume: 54
  start-page: 1.30.1
  year: 2016
  end-page: 1.30.33
  ident: bib0021
  article-title: The GeneCards suite: from gene data mining to disease genome sequence analyses
  publication-title: Curr Protoc Bioinform
  contributor:
    fullname: Plaschkes
– volume: 2021
  year: 2021
  ident: bib0030
  article-title: Interpreting the molecular mechanisms of yinchenhao decoction on hepatocellular carcinoma through absorbed components based on network pharmacology
  publication-title: Biomed Res Int
  contributor:
    fullname: Yang
– volume: 10
  start-page: 3026
  year: 2015
  end-page: 3034
  ident: bib0056
  article-title: Elevated Src expression associated with hepatocellular carcinoma metastasis in northern Chinese patients
  publication-title: Oncol Lett
  contributor:
    fullname: Wang
– volume: 354
  year: 2022
  ident: bib0052
  article-title: Peroxisome proliferator-activated receptor-γ ameliorates neuronal ferroptosis after traumatic brain injury in mice by inhibiting cyclooxygenase-2
  publication-title: Exp Neurol
  contributor:
    fullname: Huang
– volume: 12
  start-page: 5279
  year: 2021
  end-page: 5288
  ident: bib0046
  article-title: Interleukin-6 promotes ferroptosis in bronchial epithelial cells by inducing reactive oxygen species-dependent lipid peroxidation and disrupting iron homeostasis
  publication-title: Bioengineered
  contributor:
    fullname: Yang
– volume: 25
  start-page: 25
  year: 2000
  end-page: 29
  ident: bib0033
  article-title: Gene ontology: tool for the unification of biology. The gene ontology consortium
  publication-title: Nat Genet
  contributor:
    fullname: Blake
– volume: 296
  year: 2021
  ident: bib0051
  article-title: Ferroptosis drives photoreceptor degeneration in mice with defects in all-trans-retinal clearance
  publication-title: J Biol Chem
  contributor:
    fullname: Wang
– volume: 185
  start-page: 813
  year: 2021
  end-page: 820
  ident: bib0017
  article-title: Enhancement of interferon gamma stability as an anticancer therapeutic protein against hepatocellular carcinoma upon interaction with calycosin
  publication-title: Int J Biol Macromol
  contributor:
    fullname: Sun
– volume: 520
  start-page: 160
  year: 2021
  end-page: 171
  ident: bib0066
  article-title: Phosphorylation of intestine-specific homeobox by ERK1 modulates oncogenic activity and sorafenib resistance
  publication-title: Cancer Lett
  contributor:
    fullname: Chiou
– volume: 2013
  year: 2013
  ident: bib0016
  article-title: Profiling of hepatocellular carcinoma cell cycle regulating genes targeted by calycosin
  publication-title: Biomed Res Int
  contributor:
    fullname: Zhu
– volume: 23
  start-page: bbab425
  year: 2021
  ident: bib0037
  article-title: Botanical drugs: a new strategy for structure-based target prediction
  publication-title: Brief Bioinform
  contributor:
    fullname: Cheng
– volume: 242
  year: 2019
  ident: bib0015
  article-title: In vitro and in vivo study on glioma treatment enhancement by combining temozolomide with calycosin and formononetin
  publication-title: J Ethnopharmacol
  contributor:
    fullname: Zhang
– volume: 13
  start-page: 515
  year: 2021
  end-page: 531
  ident: bib0055
  article-title: PLG inhibits Hippo signaling pathway through SRC in the hepatitis B virus-induced hepatocellular-carcinoma progression
  publication-title: Am J Transl Res
  contributor:
    fullname: Huang
– volume: 524
  start-page: 161
  year: 2022
  end-page: 171
  ident: bib0045
  article-title: Induction of IL-6Rα by ATF3 enhances IL-6 mediated sorafenib and regorafenib resistance in hepatocellular carcinoma
  publication-title: Cancer Lett
  contributor:
    fullname: Peng
– year: 2022
  ident: bib0060
  article-title: Daidzin inhibits hepatocellular carcinoma survival by interfering with the glycolytic/gluconeogenic pathway through downregulation of TPI1
  publication-title: Biofactors
  contributor:
    fullname: Qu
– volume: 133
  start-page: 1732
  year: 2013
  end-page: 1742
  ident: bib0010
  article-title: Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib
  publication-title: Int J Cancer
  contributor:
    fullname: Godin
– start-page: gkac297
  year: 2022
  ident: bib0025
  article-title: SuperPred 3.0: drug classification and target prediction-a machine learning approach
  publication-title: Nucleic Acids Res
  contributor:
    fullname: Preissner
– volume: 12
  start-page: 3945
  year: 2021
  end-page: 3957
  ident: bib0048
  article-title: MicroRNA-30a-3p acts as a tumor suppressor in MHCC-97H hepatocellular carcinoma cells by targeting COX-2
  publication-title: J Cancer
  contributor:
    fullname: Sun
– volume: 386
  start-page: 1546
  year: 2015
  end-page: 1555
  ident: bib0004
  article-title: Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013
  publication-title: Lancet
  contributor:
    fullname: Mikolajczyk
– volume: 26
  start-page: 62
  year: 2021
  ident: bib0044
  article-title: Genetic and biochemical studies of hepatic carcinoma in the Egyptian population
  publication-title: J Res Med Sci
  contributor:
    fullname: Elsaid
– volume: 12
  year: 2021
  ident: bib0018
  article-title: Medical significance of uterine corpus endometrial carcinoma patients infected with SARS-CoV-2 and pharmacological characteristics of plumbagin
  publication-title: Front Endocrinol
  contributor:
    fullname: Li
– volume: 6
  start-page: 21146
  year: 2016
  ident: bib0028
  article-title: BATMAN-TCM: a Bioinformatics Analysis Tool for Molecular echanism of Traditional Chinese Medicine
  publication-title: Sci Rep
  contributor:
    fullname: Wang
– volume: 66
  start-page: 105
  year: 2012
  end-page: 143
  ident: bib0065
  article-title: ERK1/2 MAP kinases: structure, function, and regulation
  publication-title: Pharmacol Res
  contributor:
    fullname: Roskoski
– volume: 9
  start-page: 1069
  year: 2012
  end-page: 1076
  ident: bib0032
  article-title: A travel guide to Cytoscape plugins
  publication-title: Nat Methods
  contributor:
    fullname: Ono
– volume: 24
  start-page: 1
  year: 2021
  end-page: 12
  ident: bib0041
  article-title: Ferroptosis: an iron-dependent cell death form linking metabolism, diseases, immune cell and targeted therapy
  publication-title: Clin Transl Oncol
  contributor:
    fullname: Huang
– volume: 131
  year: 2021
  ident: bib0062
  article-title: Gluconeogenic enzyme PCK1 deficiency promotes CHK2 O-GlcNAcylation and hepatocellular carcinoma growth upon glucose deprivation
  publication-title: J Clin Investig
  contributor:
    fullname: Liu
– volume: 141
  year: 2021
  ident: bib0042
  article-title: Cancer: the role of iron and ferroptosis
  publication-title: Int J Biochem Cell Biol
  contributor:
    fullname: Subramaniam
– volume: 45
  start-page: D158
  year: 2017
  end-page: D169
  ident: bib0023
  article-title: UniProt: the universal protein knowledgebase
  publication-title: Nucleic Acids Res
  contributor:
    fullname: The UniProt Consortium
– volume: 54
  start-page: 1078
  year: 1998
  end-page: 1084
  ident: bib0034
  article-title: Protein Data Bank (PDB): database of three-dimensional structural information of biological macromolecules
  publication-title: Acta Crystallogr D Biol Crystallogr
  contributor:
    fullname: Jiang
– volume: 12
  start-page: 9111
  year: 2021
  end-page: 9127
  ident: bib0049
  article-title: Selenium-rich royal jelly inhibits hepatocellular carcinoma through PI3K/AKT and VEGF pathways in H22 tumor-bearing mice
  publication-title: Food Funct
  contributor:
    fullname: Wei
– volume: 70
  year: 2021
  ident: bib0014
  article-title: Calycosin induces mitochondrial-dependent apoptosis and cell cycle arrest, and inhibits cell migration through a ROS-mediated signaling pathway in HepG2 hepatocellular carcinoma cells
  publication-title: Toxicol In Vitro
  contributor:
    fullname: Xu
– volume: 46
  start-page: D1074
  year: 2018
  end-page: D1082
  ident: bib0029
  article-title: DrugBank 5.0: a major update to the DrugBank database for 2018
  publication-title: Nucleic Acids Res
  contributor:
    fullname: Guo
– volume: 47
  start-page: W357
  year: 2019
  end-page: W364
  ident: bib0024
  article-title: SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules
  publication-title: Nucleic Acids Res
  contributor:
    fullname: Zoete
– volume: 60
  start-page: 990
  year: 2022
  end-page: 996
  ident: bib0040
  article-title: Calycosin plays a protective role in diabetic kidney disease through the regulation of ferroptosis
  publication-title: Pharm Biol
  contributor:
    fullname: Wang
– volume: 11
  start-page: 8092
  year: 2021
  end-page: 8111
  ident: bib0054
  article-title: N-terminus-independent activation of c-Src via binding to a tetraspan(in) TM4SF5 in hepatocellular carcinoma is abolished by the TM4SF5 C-terminal peptide application
  publication-title: Theranostics
  contributor:
    fullname: Kim
– volume: 22
  start-page: 9453
  year: 2021
  ident: bib0063
  article-title: New insight into the effects of metformin on diabetic retinopathy, aging and cancer: nonapoptotic cell death, immunosuppression, and effects beyond the AMPK pathway
  publication-title: Int J Mol Sci
  contributor:
    fullname: Mgbeahuruike
– volume: 22
  start-page: 266
  year: 2021
  end-page: 282
  ident: bib0011
  article-title: Ferroptosis: mechanisms, biology and role in disease
  publication-title: Nat Rev Mol Cell Biol
  contributor:
    fullname: Conrad
– volume: 69
  start-page: 1057
  year: 2018
  end-page: 1065
  ident: bib0067
  article-title: Phospho-ERK is a biomarker of response to a synthetic lethal drug combination of sorafenib and MEK inhibition in liver cancer
  publication-title: J Hepatol
  contributor:
    fullname: Gao
– volume: 6
  start-page: 21146
  year: 2016
  ident: 10.1016/j.imed.2022.06.001_bib0028
  article-title: BATMAN-TCM: a Bioinformatics Analysis Tool for Molecular echanism of Traditional Chinese Medicine
  publication-title: Sci Rep
  doi: 10.1038/srep21146
  contributor:
    fullname: Liu
– volume: 12
  year: 2021
  ident: 10.1016/j.imed.2022.06.001_bib0019
  article-title: Integrated analysis and finding reveal anti-liver cancer targets and mechanisms of pachyman (Poria cocos Polysaccharides)
  publication-title: Front Pharmacol
  doi: 10.3389/fphar.2021.742349
  contributor:
    fullname: Qin
– volume: 689
  year: 2020
  ident: 10.1016/j.imed.2022.06.001_bib0064
  article-title: Role of carbonic anhydrases in ferroptosis-resistance
  publication-title: Arch Biochem Biophys
  doi: 10.1016/j.abb.2020.108440
  contributor:
    fullname: Li
– volume: 44
  start-page: D1045
  issue: D1
  year: 2016
  ident: 10.1016/j.imed.2022.06.001_bib0026
  article-title: BindingDB in 2015: a public database for medicinal chemistry, computational chemistry and systems pharmacology
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkv1072
  contributor:
    fullname: Gilson
– volume: 10
  start-page: 3026
  issue: 5
  year: 2015
  ident: 10.1016/j.imed.2022.06.001_bib0056
  article-title: Elevated Src expression associated with hepatocellular carcinoma metastasis in northern Chinese patients
  publication-title: Oncol Lett
  doi: 10.3892/ol.2015.3706
  contributor:
    fullname: Zhao
– volume: 54
  start-page: 1078
  issue: Pt 6 Pt 1
  year: 1998
  ident: 10.1016/j.imed.2022.06.001_bib0034
  article-title: Protein Data Bank (PDB): database of three-dimensional structural information of biological macromolecules
  publication-title: Acta Crystallogr D Biol Crystallogr
  doi: 10.1107/S0907444998009378
  contributor:
    fullname: Sussman
– volume: 12
  start-page: 133
  issue: 1
  year: 2019
  ident: 10.1016/j.imed.2022.06.001_bib0006
  article-title: Tumorigenesis, diagnosis, and therapeutic potential of exosomes in liver cancer
  publication-title: J Hematol Oncol
  doi: 10.1186/s13045-019-0806-6
  contributor:
    fullname: Wang
– volume: 9
  start-page: 1069
  issue: 11
  year: 2012
  ident: 10.1016/j.imed.2022.06.001_bib0032
  article-title: A travel guide to Cytoscape plugins
  publication-title: Nat Methods
  doi: 10.1038/nmeth.2212
  contributor:
    fullname: Saito
– volume: 174
  start-page: 250
  year: 2021
  ident: 10.1016/j.imed.2022.06.001_bib0050
  article-title: N2L, a novel lipoic acid-niacin dimer, attenuates ferroptosis and decreases lipid peroxidation in HT22 cells
  publication-title: Brain Res Bull
  doi: 10.1016/j.brainresbull.2021.06.014
  contributor:
    fullname: Peng
– volume: 2013
  year: 2013
  ident: 10.1016/j.imed.2022.06.001_bib0016
  article-title: Profiling of hepatocellular carcinoma cell cycle regulating genes targeted by calycosin
  publication-title: Biomed Res Int
  doi: 10.1155/2013/317926
  contributor:
    fullname: Zhang
– volume: 185
  start-page: 813
  year: 2021
  ident: 10.1016/j.imed.2022.06.001_bib0017
  article-title: Enhancement of interferon gamma stability as an anticancer therapeutic protein against hepatocellular carcinoma upon interaction with calycosin
  publication-title: Int J Biol Macromol
  doi: 10.1016/j.ijbiomac.2021.06.159
  contributor:
    fullname: Yang
– volume: 12
  start-page: 9111
  issue: 19
  year: 2021
  ident: 10.1016/j.imed.2022.06.001_bib0049
  article-title: Selenium-rich royal jelly inhibits hepatocellular carcinoma through PI3K/AKT and VEGF pathways in H22 tumor-bearing mice
  publication-title: Food Funct
  doi: 10.1039/D1FO01070K
  contributor:
    fullname: Chi
– year: 2022
  ident: 10.1016/j.imed.2022.06.001_bib0060
  article-title: Daidzin inhibits hepatocellular carcinoma survival by interfering with the glycolytic/gluconeogenic pathway through downregulation of TPI1
  publication-title: Biofactors
  doi: 10.1002/biof.1826
  contributor:
    fullname: Li
– volume: 70
  year: 2019
  ident: 10.1016/j.imed.2022.06.001_bib0012
  article-title: Bioinformatic and experimental data decipher the pharmacological targets and mechanisms of plumbagin against hepatocellular carcinoma
  publication-title: Environ Toxicol Pharmacol
  doi: 10.1016/j.etap.2019.103200
  contributor:
    fullname: Zhou
– volume: 242
  year: 2019
  ident: 10.1016/j.imed.2022.06.001_bib0015
  article-title: In vitro and in vivo study on glioma treatment enhancement by combining temozolomide with calycosin and formononetin
  publication-title: J Ethnopharmacol
  doi: 10.1016/j.jep.2019.01.023
  contributor:
    fullname: Ni
– volume: 47
  start-page: W357
  issue: W1
  year: 2019
  ident: 10.1016/j.imed.2022.06.001_bib0024
  article-title: SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkz382
  contributor:
    fullname: Daina
– volume: 29
  start-page: 467
  year: 2022
  ident: 10.1016/j.imed.2022.06.001_bib0008
  article-title: The multifaceted role of ferroptosis in liver disease
  publication-title: Cell Death Differ
  doi: 10.1038/s41418-022-00941-0
  contributor:
    fullname: Chen
– volume: 60
  start-page: 990
  issue: 1
  year: 2022
  ident: 10.1016/j.imed.2022.06.001_bib0040
  article-title: Calycosin plays a protective role in diabetic kidney disease through the regulation of ferroptosis
  publication-title: Pharm Biol
  doi: 10.1080/13880209.2022.2067572
  contributor:
    fullname: Huang
– volume: 43
  start-page: e47
  issue: 7
  year: 2015
  ident: 10.1016/j.imed.2022.06.001_bib0020
  article-title: limma powers differential expression analyses for RNA-sequencing and microarray studies
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkv007
  contributor:
    fullname: Ritchie
– volume: 45
  start-page: D158
  issue: D1
  year: 2017
  ident: 10.1016/j.imed.2022.06.001_bib0023
  article-title: UniProt: the universal protein knowledgebase
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkw1099
  contributor:
    fullname: The UniProt Consortium
– volume: 11
  start-page: 8092
  issue: 16
  year: 2021
  ident: 10.1016/j.imed.2022.06.001_bib0054
  article-title: N-terminus-independent activation of c-Src via binding to a tetraspan(in) TM4SF5 in hepatocellular carcinoma is abolished by the TM4SF5 C-terminal peptide application
  publication-title: Theranostics
  doi: 10.7150/thno.58739
  contributor:
    fullname: Song
– volume: 26
  start-page: 62
  year: 2021
  ident: 10.1016/j.imed.2022.06.001_bib0044
  article-title: Genetic and biochemical studies of hepatic carcinoma in the Egyptian population
  publication-title: J Res Med Sci
  doi: 10.4103/jrms.JRMS_846_17
  contributor:
    fullname: Elkhoudary
– volume: 31
  start-page: 339
  issue: 4
  year: 2002
  ident: 10.1016/j.imed.2022.06.001_bib0036
  article-title: Molecular pathogenesis of human hepatocellular carcinoma
  publication-title: Nat Genet
  doi: 10.1038/ng0802-339
  contributor:
    fullname: Thorgeirsson
– volume: 16
  start-page: 589
  year: 2019
  ident: 10.1016/j.imed.2022.06.001_bib0003
  article-title: A global view of hepatocellular carcinoma: trends, risk, prevention and management
  publication-title: Nat Rev Gastroenterol Hepatol
  doi: 10.1038/s41575-019-0186-y
  contributor:
    fullname: Yang
– volume: 386
  start-page: 1546
  issue: 10003
  year: 2015
  ident: 10.1016/j.imed.2022.06.001_bib0004
  article-title: Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013
  publication-title: Lancet
  doi: 10.1016/S0140-6736(15)61412-X
  contributor:
    fullname: Schweitzer
– volume: 66
  start-page: 105
  issue: 2
  year: 2012
  ident: 10.1016/j.imed.2022.06.001_bib0065
  article-title: ERK1/2 MAP kinases: structure, function, and regulation
  publication-title: Pharmacol Res
  doi: 10.1016/j.phrs.2012.04.005
  contributor:
    fullname: Roskoski
– volume: 2021
  year: 2021
  ident: 10.1016/j.imed.2022.06.001_bib0030
  article-title: Interpreting the molecular mechanisms of yinchenhao decoction on hepatocellular carcinoma through absorbed components based on network pharmacology
  publication-title: Biomed Res Int
  contributor:
    fullname: Sun
– volume: 40
  issue: 20
  year: 2021
  ident: 10.1016/j.imed.2022.06.001_bib0053
  article-title: RASSF1C oncogene elicits amoeboid invasion, cancer stemness, and extracellular vesicle release via a SRC/Rho axis
  publication-title: EMBO J
  doi: 10.15252/embj.2021107680
  contributor:
    fullname: Tognoli
– volume: 46
  start-page: D1074
  issue: D1
  year: 2018
  ident: 10.1016/j.imed.2022.06.001_bib0029
  article-title: DrugBank 5.0: a major update to the DrugBank database for 2018
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkx1037
  contributor:
    fullname: Wishart
– volume: 13
  start-page: 515
  issue: 2
  year: 2021
  ident: 10.1016/j.imed.2022.06.001_bib0055
  article-title: PLG inhibits Hippo signaling pathway through SRC in the hepatitis B virus-induced hepatocellular-carcinoma progression
  publication-title: Am J Transl Res
  contributor:
    fullname: Hu
– volume: 12
  start-page: 3945
  issue: 13
  year: 2021
  ident: 10.1016/j.imed.2022.06.001_bib0048
  article-title: MicroRNA-30a-3p acts as a tumor suppressor in MHCC-97H hepatocellular carcinoma cells by targeting COX-2
  publication-title: J Cancer
  doi: 10.7150/jca.52298
  contributor:
    fullname: Yang
– volume: 40
  start-page: 6707
  issue: 50
  year: 2021
  ident: 10.1016/j.imed.2022.06.001_bib0061
  article-title: O-GlcNAc modified-TIP60/KAT5 is required for PCK1 deficiency-induced HCC metastasis
  publication-title: Oncogene
  doi: 10.1038/s41388-021-02058-z
  contributor:
    fullname: Liu
– start-page: gkac297
  year: 2022
  ident: 10.1016/j.imed.2022.06.001_bib0025
  article-title: SuperPred 3.0: drug classification and target prediction-a machine learning approach
  publication-title: Nucleic Acids Res
  contributor:
    fullname: Gallo
– volume: 133
  start-page: 130
  year: 2019
  ident: 10.1016/j.imed.2022.06.001_bib0009
  article-title: The development of the concept of ferroptosis
  publication-title: Free Radic Biol Med
  doi: 10.1016/j.freeradbiomed.2018.09.043
  contributor:
    fullname: Hirschhorn
– volume: 131
  issue: 8
  year: 2021
  ident: 10.1016/j.imed.2022.06.001_bib0062
  article-title: Gluconeogenic enzyme PCK1 deficiency promotes CHK2 O-GlcNAcylation and hepatocellular carcinoma growth upon glucose deprivation
  publication-title: J Clin Investig
  doi: 10.1172/JCI144703
  contributor:
    fullname: Xiang
– volume: 24
  start-page: 1
  issue: 1
  year: 2021
  ident: 10.1016/j.imed.2022.06.001_bib0041
  article-title: Ferroptosis: an iron-dependent cell death form linking metabolism, diseases, immune cell and targeted therapy
  publication-title: Clin Transl Oncol
  doi: 10.1007/s12094-021-02669-8
  contributor:
    fullname: Li
– volume: 71
  start-page: 7
  year: 2021
  ident: 10.1016/j.imed.2022.06.001_bib0002
  article-title: Cancer Statistics, 2021
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21654
  contributor:
    fullname: Siegel
– volume: 12
  year: 2021
  ident: 10.1016/j.imed.2022.06.001_bib0018
  article-title: Medical significance of uterine corpus endometrial carcinoma patients infected with SARS-CoV-2 and pharmacological characteristics of plumbagin
  publication-title: Front Endocrinol
  doi: 10.3389/fendo.2021.714909
  contributor:
    fullname: Li
– volume: 70
  year: 2021
  ident: 10.1016/j.imed.2022.06.001_bib0014
  article-title: Calycosin induces mitochondrial-dependent apoptosis and cell cycle arrest, and inhibits cell migration through a ROS-mediated signaling pathway in HepG2 hepatocellular carcinoma cells
  publication-title: Toxicol In Vitro
  doi: 10.1016/j.tiv.2020.105052
  contributor:
    fullname: Liu
– volume: 225
  year: 2021
  ident: 10.1016/j.imed.2022.06.001_bib0047
  article-title: Synthetically-tailored and nature-derived dual COX-2/5-LOX inhibitors: structural aspects and SAR
  publication-title: Eur J Med Chem
  doi: 10.1016/j.ejmech.2021.113804
  contributor:
    fullname: Meshram
– volume: 11
  start-page: 8402
  issue: 1
  year: 2021
  ident: 10.1016/j.imed.2022.06.001_bib0035
  article-title: The mechanism of TiaoGanYiPi formula for treating chronic hepatitis B by network pharmacology and molecular docking verification
  publication-title: Sci Rep
  doi: 10.1038/s41598-021-87812-9
  contributor:
    fullname: Cao
– volume: 11
  start-page: 4765
  issue: 5
  year: 2020
  ident: 10.1016/j.imed.2022.06.001_bib0031
  article-title: Therapeutic target and molecular mechanism of vitamin C-treated pneumonia: a systematic study of network pharmacology
  publication-title: Food Funct
  doi: 10.1039/D0FO00421A
  contributor:
    fullname: Li
– volume: 34
  start-page: 177
  issue: 1
  year: 2021
  ident: 10.1016/j.imed.2022.06.001_bib0068
  article-title: Molecular characteristics associated with ferroptosis in hepatocellular carcinoma progression
  publication-title: Hum Cell
  doi: 10.1007/s13577-020-00431-w
  contributor:
    fullname: Fei
– volume: 524
  start-page: 161
  year: 2022
  ident: 10.1016/j.imed.2022.06.001_bib0045
  article-title: Induction of IL-6Rα by ATF3 enhances IL-6 mediated sorafenib and regorafenib resistance in hepatocellular carcinoma
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2021.10.024
  contributor:
    fullname: Dai
– volume: 35
  start-page: 68
  issue: 1
  year: 2001
  ident: 10.1016/j.imed.2022.06.001_bib0057
  article-title: Activation of c-Src gene product in hepatocellular carcinoma is highly correlated with the indices of early stage phenotype
  publication-title: J Hepatol
  doi: 10.1016/S0168-8278(01)00077-0
  contributor:
    fullname: Ito
– volume: 141
  year: 2021
  ident: 10.1016/j.imed.2022.06.001_bib0042
  article-title: Cancer: the role of iron and ferroptosis
  publication-title: Int J Biochem Cell Biol
  doi: 10.1016/j.biocel.2021.106094
  contributor:
    fullname: Rishi
– volume: 520
  start-page: 160
  year: 2021
  ident: 10.1016/j.imed.2022.06.001_bib0066
  article-title: Phosphorylation of intestine-specific homeobox by ERK1 modulates oncogenic activity and sorafenib resistance
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2021.07.011
  contributor:
    fullname: Wang
– volume: 2020
  start-page: baaa021
  year: 2020
  ident: 10.1016/j.imed.2022.06.001_bib0022
  article-title: FerrDb: a manually curated resource for regulators and markers of ferroptosis and ferroptosis-disease associations
  publication-title: Database
  doi: 10.1093/database/baaa021
  contributor:
    fullname: Zhou
– volume: 380
  start-page: 1450
  year: 2019
  ident: 10.1016/j.imed.2022.06.001_bib0001
  article-title: Hepatocellular Carcinoma
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra1713263
  contributor:
    fullname: Villanueva
– volume: 12
  start-page: 9939
  issue: 2
  year: 2021
  ident: 10.1016/j.imed.2022.06.001_bib0013
  article-title: Exploring anti-liver cancer targets and mechanisms of oxyresveratrol: in silico and verified findings
  publication-title: Bioengineered
  doi: 10.1080/21655979.2021.1985328
  contributor:
    fullname: Zhao
– volume: 296
  year: 2021
  ident: 10.1016/j.imed.2022.06.001_bib0051
  article-title: Ferroptosis drives photoreceptor degeneration in mice with defects in all-trans-retinal clearance
  publication-title: J Biol Chem
  doi: 10.1074/jbc.RA120.015779
  contributor:
    fullname: Chen
– volume: 12
  start-page: 5279
  issue: 1
  year: 2021
  ident: 10.1016/j.imed.2022.06.001_bib0046
  article-title: Interleukin-6 promotes ferroptosis in bronchial epithelial cells by inducing reactive oxygen species-dependent lipid peroxidation and disrupting iron homeostasis
  publication-title: Bioengineered
  doi: 10.1080/21655979.2021.1964158
  contributor:
    fullname: Han
– volume: 25
  start-page: 25
  issue: 1
  year: 2000
  ident: 10.1016/j.imed.2022.06.001_bib0033
  article-title: Gene ontology: tool for the unification of biology. The gene ontology consortium
  publication-title: Nat Genet
  doi: 10.1038/75556
  contributor:
    fullname: Ashburner
– volume: 23
  start-page: bbab425
  issue: 1
  year: 2021
  ident: 10.1016/j.imed.2022.06.001_bib0037
  article-title: Botanical drugs: a new strategy for structure-based target prediction
  publication-title: Brief Bioinform
  doi: 10.1093/bib/bbab425
  contributor:
    fullname: Wei
– volume: 11
  start-page: e600
  issue: 10
  year: 2021
  ident: 10.1016/j.imed.2022.06.001_bib0005
  article-title: Ultrasound-guided percutaneous metal-organic frameworks based codelivery system of doxorubicin/acetazolamide for hepatocellular carcinoma therapy
  publication-title: Clin Transl Med
  doi: 10.1002/ctm2.600
  contributor:
    fullname: Jing
– volume: 30
  start-page: 413
  issue: 5
  year: 2016
  ident: 10.1016/j.imed.2022.06.001_bib0027
  article-title: TargetNet: a web service for predicting potential drug-target interaction profiling via multi-target SAR models
  publication-title: J Comput Aided Mol Des
  doi: 10.1007/s10822-016-9915-2
  contributor:
    fullname: Yao
– volume: 22
  start-page: 266
  issue: 4
  year: 2021
  ident: 10.1016/j.imed.2022.06.001_bib0011
  article-title: Ferroptosis: mechanisms, biology and role in disease
  publication-title: Nat Rev Mol Cell Biol
  doi: 10.1038/s41580-020-00324-8
  contributor:
    fullname: Jiang
– volume: 354
  year: 2022
  ident: 10.1016/j.imed.2022.06.001_bib0052
  article-title: Peroxisome proliferator-activated receptor-γ ameliorates neuronal ferroptosis after traumatic brain injury in mice by inhibiting cyclooxygenase-2
  publication-title: Exp Neurol
  doi: 10.1016/j.expneurol.2022.114100
  contributor:
    fullname: Liang
– volume: 133
  start-page: 1732
  issue: 7
  year: 2013
  ident: 10.1016/j.imed.2022.06.001_bib0010
  article-title: Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib
  publication-title: Int J Cancer
  doi: 10.1002/ijc.28159
  contributor:
    fullname: Louandre
– volume: 54
  start-page: 1.30.1
  year: 2016
  ident: 10.1016/j.imed.2022.06.001_bib0021
  article-title: The GeneCards suite: from gene data mining to disease genome sequence analyses
  publication-title: Curr Protoc Bioinform
  doi: 10.1002/cpbi.5
  contributor:
    fullname: Stelzer
– volume: 22
  start-page: 9453
  issue: 17
  year: 2021
  ident: 10.1016/j.imed.2022.06.001_bib0063
  article-title: New insight into the effects of metformin on diabetic retinopathy, aging and cancer: nonapoptotic cell death, immunosuppression, and effects beyond the AMPK pathway
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms22179453
  contributor:
    fullname: Hsu
– volume: 179
  start-page: 561
  issue: 2
  year: 2019
  ident: 10.1016/j.imed.2022.06.001_bib0007
  article-title: Integrated proteogenomic characterization of HBV-related hepatocellular carcinoma
  publication-title: Cell
  doi: 10.1016/j.cell.2019.08.052
  contributor:
    fullname: Gao
– volume: 10
  start-page: e15263
  issue: 9
  year: 2022
  ident: 10.1016/j.imed.2022.06.001_bib0058
  article-title: Glucagon, cyclic AMP, and hepatic glucose mobilization: a half-century of uncertainty
  publication-title: Physiol Rep
  doi: 10.14814/phy2.15263
  contributor:
    fullname: Rodgers
– year: 2021
  ident: 10.1016/j.imed.2022.06.001_bib0043
  article-title: Iron and liver cancer: an inseparable connection
  publication-title: FEBS J
  contributor:
    fullname: Hino
– volume: 69
  start-page: 1057
  issue: 5
  year: 2018
  ident: 10.1016/j.imed.2022.06.001_bib0067
  article-title: Phospho-ERK is a biomarker of response to a synthetic lethal drug combination of sorafenib and MEK inhibition in liver cancer
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2018.07.004
  contributor:
    fullname: Wang
– volume: 32
  start-page: 35
  issue: 1
  year: 2022
  ident: 10.1016/j.imed.2022.06.001_bib0059
  article-title: MiR-93-5P represses the gluconeogenesis of hepatocellular carcinoma while boosting its glycolysis and malignant progression by suppressing PCK1
  publication-title: Crit Rev Eukaryot Gene Expr
  doi: 10.1615/CritRevEukaryotGeneExpr.2021038907
  contributor:
    fullname: Zhou
SSID ssj0002709444
Score 2.2819085
Snippet Ferroptosis, a pathologic state induced by lipid-driven oxidative stress, is associated with the development of human cancers. Calycosin, a natural compound...
Background: Ferroptosis, a pathologic state induced by lipid-driven oxidative stress, is associated with the development of human cancers. Calycosin, a natural...
SourceID doaj
crossref
elsevier
SourceType Open Website
Aggregation Database
Publisher
StartPage 173
SubjectTerms Bioinformatics
Calycosin
Ferroptosis
Hepatic carcinoma
Pharmacologic target
Title Anti-hepatic carcinoma mechanisms of calycosin through targeting ferroptosis
URI https://dx.doi.org/10.1016/j.imed.2022.06.001
https://doaj.org/article/7878de01465c4fa29ebff2df268a8075
Volume 3
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV09T8MwELVQJxYEAkT5UgY2FKjtxE7GglohRJmo1M1ynLNIRZOqCQMLv51znKKwwMKSwbHi6Nnyu5Of3xFylRgBieEyzJGdwyiKeai5FqFOuNAjjTFIe4I_exYP8-hxES96pb6cJszbA3vgbnFBJTk4i5PYRFazFDJrWW6ZSLQz0m13Xxr3kqlle5yGaUtbyRUJSOJew0R3Y8aLuwqkGkwOGbvxhxE_WKk17--RU49wpvtkr4sUg7H_wwOyA-UheRqXTRG-gtNBm8C4QkBltdLBCtwN3qJe1UFlsf3tw1R1UQZdGZ7AC76RpgILm021bvBtfUTm08nL_UPYFUQIDRe0waTRAAUBlELCKRM8G_EY0c5t6qwNMdNCcuZANU2xY4ZUE7sIAwwbSW3ylB-TQVmVcEICKSUFTjNLE4hyTPKEYMxSDVpaaRMzJNdbQNTa-16orSBsqRx8ysGnvCpuSO4cZt89nWd124AzqbqZVH_N5JDEW8RVR_-e1vFTxS-Dn_7H4Gdk1xWS99K-czJoNu9wgeFGk122Kwufs8_JF20w0VQ
link.rule.ids 315,786,790,870,2115,27955,27956
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Anti-hepatic+carcinoma+mechanisms+of+calycosin+through+targeting+ferroptosis&rft.jtitle=Intelligent+medicine&rft.au=Nie%2C+Litao&rft.au=Liao%2C+Yimei&rft.au=Zhou%2C+Rui&rft.au=Liang%2C+Xiao&rft.date=2023-08-01&rft.issn=2667-1026&rft.volume=3&rft.issue=3&rft.spage=173&rft.epage=179&rft_id=info:doi/10.1016%2Fj.imed.2022.06.001&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_imed_2022_06_001
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2667-1026&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2667-1026&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2667-1026&client=summon